Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.93 USD | +6.46% | -12.92% | -29.66% |
16/05 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
08/04 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.66% | 364M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.13% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 08